Efficacy of chemotherapy plus bevacizumab as first-line therapy in patients with metastatic colorectal cancer: a meta-analysis and up-date
about
Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysis.Bevacizumab Combined with Chemotherapy Improves Survival for Patients with Metastatic Colorectal Cancer: Evidence from Meta Analysis.The addition of bevacizumab in the first-line treatment for metastatic colorectal cancer: an updated meta-analysis of randomized trials.
P2860
Efficacy of chemotherapy plus bevacizumab as first-line therapy in patients with metastatic colorectal cancer: a meta-analysis and up-date
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Efficacy of chemotherapy plus ...... r: a meta-analysis and up-date
@ast
Efficacy of chemotherapy plus ...... r: a meta-analysis and up-date
@en
type
label
Efficacy of chemotherapy plus ...... r: a meta-analysis and up-date
@ast
Efficacy of chemotherapy plus ...... r: a meta-analysis and up-date
@en
prefLabel
Efficacy of chemotherapy plus ...... r: a meta-analysis and up-date
@ast
Efficacy of chemotherapy plus ...... r: a meta-analysis and up-date
@en
P2093
P2860
P1476
Efficacy of chemotherapy plus ...... r: a meta-analysis and up-date
@en
P2093
Caizhao Lin
Guoliang Zhang
P2860
P304
P577
2015-01-15T00:00:00Z